Shares of Gilead Sciences Inc. GILD, -0.83% slid 0.83% to $64.47 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +1.99% rising 1.99% to 4,057.84 and the Dow Jones Industrial Average DJIA, +1.61% rising 1.61% to 32,637.19. The stock’s fall snapped a two-day winning streak. Gilead Sciences Inc. closed $9.65 below its 52-week high ($74.12), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.09% fell 0.09% to $179.46, Merck & Co. Inc. MRK, -1.54% fell 1.54% to $92.31, and AbbVie Inc. ABBV, -0.91% fell 0.91% to $150.57. Trading volume (5.7 M) remained 3.0 million below its 50-day average volume of 8.7 M.